Abiopharma

New Form 8-K - Ultragenyx Pharmaceutical Inc. Filed: 2025-08-05 AccNo: 0000950170-25-103026 Size: 537 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits